Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FD5T4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,903
Award facts
- Contract value 100% obligated
- $28,903.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,903.24 to AmerisourceBergen Drug Corp for the supply of Wegovy 1 mg/0.5 mL pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and healthcare system procurement needs. The company's contract portfolio with the DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. This delivery order for Wegovy, a GLP-1 receptor agonist medication, reflects the company's role in supporting military healthcare programs with specialized pharmaceutical commodities. The DLA's Pharmaceutical Prime Vendor Global Program is anticipated to expand with multiple regional contract awards, positioning AmerisourceBergen among the approved vendors for continued federal pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DB25FD5T4?
SPE2DB25FD5T4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FD5T4 worth?
The government has obligated $28,903 on SPE2DB25FD5T4.
Is contract SPE2DB25FD5T4 an order under another contract?
Yes. SPE2DB25FD5T4 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD5T4 competed?
The extent of competition for SPE2DB25FD5T4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award